Darbepoetin Alfa in Patients with Advanced CKD without Diabetes: Randomized, Controlled Trial.

Terumasa HayashiShoichi MaruyamaMasaomi NangakuIchiei NaritaHideki HirakataKenichiro TanabeSatoshi MoritaYoshiharu TsubakiharaEnyu ImaiTadao Akizawanull null

Published in: Clinical journal of the American Society of Nephrology : CJASN (2020)

Prevention of ESKD by Darbepoetin Alfa in CKD Patients with Non-diabetic Kidney Disease (PREDICT), NCT01581073.

Keyphrases

randomized controlled trial
chronic kidney disease
type diabetes
replacement therapy
study protocol
cardiovascular disease
glycemic control
wound healing
systematic review